Update 4/10 Abrupt Sell-Off –Failure to Confirm Bottom
NASDAQ down 71 pts 1.7%
All of yesterdays’ gains wiped out and we are back to January levels.
Raise cash levels to 30% on life science portfolios. Many high fliers and core holdings are selling off today after bullish action yesterday. See ALXN,GILD, IBB, ILMN, INCY,MDVN, PCYC, XBI etc. Even XLV is down 1.38%. Could be concern about upcoming earnings or long term pricing considerations.
MOMO stocks also selling off: AMZN ICPT NFLX.
Broad Biotech Rally Starts Early- Builds Head of Steam-IBB Up 4.1%
Intermediate Support Looks Good- Bull Market Test
With the sector down 15-20 % off 2014 highs and many life science stocks barely up YTD , investors decided to jump back into what was the hottest game in town. The healthcare sector overall was up 2%, leading the market although social media and technology were also strong. Many well known large cap names soared: Alexion (ALXN), Alkermes (ALKS), Biogen Idec (BIIB), Celegene (CELG), Pharmacyclics (PCYC) , and Regeneron (REGN).
- Review Rayno Biopharmaceutical picks . All are holds.
- Large Caps should lead as they did today.
- Q1 Earnings will provide better clarity on large cap growth.
- Support for sector reset is now early January levels.